Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting.
Giorgio Mustacchi
Honoraria - Agendia; Celgene; GlaxoSmithKline; Novartis; Pierre Fabre Medicament; Roche; Sanofi
Research Funding - Roche/Genentech; Sanofi
Annamaria Molino
Honoraria - Novartis
Elena Fiorio
No relevant relationships to disclose
Antonella Brunello
No relevant relationships to disclose
Vittorina Zagonel
Honoraria - Roche
Antonella Ferro
Honoraria - Novartis; Roche
Alessia Caldara
No relevant relationships to disclose
Aldo Iop
Honoraria - Amgen; Novartis; Roche
Salvatore Bonura
No relevant relationships to disclose
Micaela Stefani
Honoraria - Novartis; Roche
Research Funding - Pierre Fabre Medicament
Daniele Bernardi
Honoraria - AstraZeneca; Celgene
Research Funding - Pierre Fabre Medicament